Tonix Share Price

Tonix Share Price

NASDAQ: TNXP | Micro Cap | Healthcare
$2.81
-$0.13 (-4.58%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Tonix Stock Performance

Open
$2.93
Prev. Close
$2.94
Circuit Range
N/A
Day Range
$2.78 - $2.98
Year Range
$2.78 - $20.49
Volume
31,096
Average Traded
$2.85

Tonix Share Price Today

As of 19 November 2026, Tonix Pharmaceuticals Holding Corp.'s share price is $2.81. The stock opened at $2.93, compared to its previous close of $2.94. During today's trading session, Tonix Pharmaceuticals Holding Corp.'s share price traded between $2.78 and $2.98, with an average price of $2.88. Over the past 52 weeks, the stock has recorded a high of $20.49 and a low of $2.78. In terms of performance, Tonix Pharmaceuticals Holding Corp.'s share price has declined by 77.27% over the last six months and is down 82.36% on a year-on-year basis.

Tonix Share Price Chart

Line chart of the Tonix price trend over the selected period. The price fell overall, ranging from 2.78 to 2.99, ending at 2.81.
$2.78$2.98
L
Show Current Price
H

Tonix Stock Fundamentals & Key Indicators

Market Cap
$23.92M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-9.31
Revenue (TTM)
$13.11B
Return On Equity (TTM)
-90.73%
Profit Margin
-946.00%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-13.69%

Tonix Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$5.39$6.88$13.54$17.23
Net Profit-$46.91-$40.19-$40.55-$53.33
Net Profit Margin-870.32%-584.16%-299.48%-309.52%
Income ChangeN/A14.33%-0.90%-31.52%

Tonix Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$7.77$10.09$13.11
Net Profit-$116.88-$116.66-$130.04-$124.02
Net Profit MarginN/A-1501.42%-1288.80%-946.00%
Income ChangeN/A0.19%-11.47%4.63%

Tonix Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets48.343.89106.6994.91
Current Assets228.88119.047.77130.78
Total Assets277.17162.89154.46225.69
Non Current Liabilities1.185.0330.050.33
Current Liabilities30.8418.3118.8818.18
Total Liabilities32.0223.3348.9318.51
Shareholders' Equity245.15139.56105.53207.18

Tonix Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-99.84-60.93-102.0-98.05
Investing-4.53-0.12-29.07-48.15
Financing214.53134.8736.5287.84

Corporate Actions

Split
Ex-date: 05 Feb 2025

Split
Ex-date: 10 Jun 2024

Split
Ex-date: 10 May 2023

Split
Ex-date: 17 May 2022

Split
Ex-date: 01 Nov 2019

Split
Ex-date: 28 Nov 2018

About Tonix

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Tonix Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$5.11
$2.81
-44.89%
Oct 2026
$9.68
$5.09
-47.74%
Sep 2026
$13.92
$9.74
-28.22%
Aug 2026
$10.01
$13.57
+35.16%
Jul 2026
$12.80
$10.04
-21.19%
Jun 2026
$12.27
$12.74
+3.07%
May 2026
$13.03
$12.36
-4.33%
Apr 2026
$14.52
$12.92
-6.10%
Mar 2026
$13.42
$13.76
-1.61%
Feb 2026
$17.12
$13.98
-18.74%
Jan 2026
$16.36
$17.21
+10.46%
Dec 2025
$15.38
$15.58
-2.20%

Tonix Share Price FAQs